ABSTRACT
TREM2 is an innate immune receptor expressed by microglia in the adult brain. Homozygous TREM2 mutations cause a rare leukodystrophy, Nasu-Hakola disease (NHD). Despite extensive investigation, the role of TREM2 in NHD pathogenesis remains poorly understood. Here, we investigate the mechanisms by which a homozygous stop-gain TREM2 mutation (p.Q33X) contributes to NHD. Induced pluripotent stem cell (iPSC)-derived microglia (iMGLs) were generated from two siblings homozygous for the TREM2 p.Q33X mutation (termed NHD), one related non-carrier, and one unrelated non-carrier. Transcriptomic and biochemical analyses reveal defective activation, HLA antigen presentation, and NF-κB signaling in NHD iMGLs. Additionally, NHD iMGLs exhibited lysosomal dysfunction, downregulation of cholesterol metabolism genes, and reduced lipid droplets. These defects were validated in brain tissue from NHD patients. Thus, stem cell models reveal novel dysfunctional lysosomal pathways in NHD microglia and capture pathological processes that also occur in human brains from NHD patients.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was funded by Centene (CMK), NIH U01 AG052411 (AG), R01 AG058501 (LP), R01 AG062734 (CMK), P30 AG066444 (JM, CMK), UL1 TR002345, and the Chan Zuckerberg Initiative; R01 NS069719 (WHR), the Takayma family gift (OK), the US Department of Veterans Affairs Clinical Sciences R&D Service (Merit Review Award Number 101 CX001702 to WHR and OK). Access to equipment was made possible by the Hope Center for Neurological Disorders, and the Departments of Neurology and Psychiatry at Washington University School of Medicine. Fabia Filipello was supported by the McDonnell Center for Cellular and Molecular Neurobiology fellowship (Washington University in St Louis) and is the recipient of a 2018-0364-CARIPLO grant. Confocal was generated on a Zeiss LSM 880 Airyscan Confocal Microscope which was purchased with support from the Office of Research Infrastructure Programs (ORIP), a part of the NIH Office of the Director under grant OD021629. The recruitment and clinical characterization of research participants at Washington University were supported by NIH P50 AG05681, P01 AG03991, and P01 AG026276.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Skin biopsies were collected following written informed consent from the control unaffected sibling or the parents for the NHD affected individuals. Participants consented to the publication of research results obtained from the donated tissues. The informed consent was approved by the Washington University School of Medicine Institutional Review Board and Ethics Committee (IRB 201104178). Under protocols approved by the Institutional Review Boards of the University of Washington and the Meiji Pharmaceutical University, all subjects had previously given informed consent to share and study autopsy material. All methods for processing and analyzing the brain autopsy tissues followed relevant guidelines and regulations.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors.